Altretamine
Catalog No. A10059
Altretamine被列为烷基化抗肿瘤药,据信这种独特的结构会通过产生弱烷基化物种甲醛(CYP450介导的N-去甲基化产物)来破坏肿瘤细胞。
Catalog Num | A10059 |
---|---|
M. Wt | 210.3 |
Formula | C9H18N6 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 645-05-6 |
Synonyms | Hexalen |
SMILES | CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C |
Altretamine被列为烷基化抗肿瘤药,据信这种独特的结构会通过产生弱烷基化物种甲醛(CYP450介导的N-去甲基化产物)来破坏肿瘤细胞。
In vitro | DMSO | 14 mg/mL (66.57 mM) | |
Water | Insoluble | ||
Ethanol | 31 mg/mL (147.42 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 47.55 mL | 237.76 mL | 475.51 mL |
0.5 mM | 9.51 mL | 47.55 mL | 95.1 mL |
1 mM | 4.76 mL | 23.78 mL | 47.55 mL |
5 mM | 0.95 mL | 4.76 mL | 9.51 mL |
*The above data is based on the productmolecular weight 210.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.